ADAP Advocacy Publishes Infographic Series on the 340B Program

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.




Infographics analyze hospital revenues and executive compensation, compared to hospital charity care and patient medical debt

WASHINGTON, DC, November 25, 2024 /24-7PressRelease/ -- ADAP Advocacy today, as part of its 340B Project, published an infographic series on the 340B Drug Pricing Program. The infographics highlight how under the program, hospital charity care is declining while medical debt is exploding despite hospital revenue growth and hospital CEO pay raises. The ADAP Advocacy-sponsored Ryan White Grantee 340B Patient Advisory Committee has increasingly focused on medical debt and its impact on patients living with chronic illnesses and rare diseases.

The 340B infographic series can be downloaded online here: https://www.adapadvocacy.org/publications.html#i.

To learn more about ADAP Advocacy or its 340B infographic series, please email info@adapadvocacy.org.

About ADAP Advocacy: ADAP Advocacy's mission is to promote and enhance the AIDS Drug Assistance Programs (ADAPs) and improves access to care for persons living with HIV/AIDS. ADAP Advocacy works with advocates, community, health care, government, patients, pharmaceutical companies, and other stakeholders to raise awareness, offer patient educational programs, and foster greater community collaboration.

---
Press release service and press release distribution provided by https://www.24-7pressrelease.com
Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  251.41
-5.56 (-2.16%)
AAPL  313.27
-2.95 (-0.93%)
AMD  523.13
+17.39 (3.44%)
BAC  62.78
+0.39 (0.63%)
GOOG  327.14
-8.24 (-2.46%)
META  649.90
+36.42 (5.94%)
MSFT  491.45
-2.50 (-0.51%)
NVDA  224.28
-1.45 (-0.64%)
ORCL  161.25
-1.27 (-0.78%)
TSLA  370.28
+2.12 (0.58%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.